| ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE | None | ||
| 325MG;6.12MG, 325MG;4.08MG, 325MG;8.16MG |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| APADAZ is a combination of benzhydrocodone, a prodrug of the opioid agonist hydrocodone, and acetaminophen, and is indicated for the short-term (no more than 14 days) management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. | |||
|
Yes
| |||
| APADAZ | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 |
|---|---|---|---|---|---|---|
| *** ********* | ||||||
| ******* ****, ******* **** *********** *** ********** ********** **** ********** ** ***********, ********, ******* ** ****** *** *** ******* | ******* ****, ******* **** *********** *** ********** ********** **** ********** ** ***********, ********, ******* ** ****** *** *** ******* | ******* ****, ******* **** *********** *** ********** ********** **** ********** ** ***********, ********, ******* ** ****** *** *** ******* | ******* ****, ******* **** *********** *** ********** ********** **** ********** ** ***********, ********, ******* ** ****** *** *** ******* | ******* ****, ******* **** *********** *** ********** ********** **** ********** ** ***********, ********, ******* ** ****** *** *** ******* | ******* ****, ******* **** *********** *** ********** ********** **** ********** ** ***********, ********, ******* ** ****** *** **** ******* |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|